☰

Anna Moszczynska, Ph.D. - Publications

Affiliations: 
2002 University of Toronto, Toronto, ON, Canada 
Area:
Neuroscience Biology
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Moszczynska A. Differential Responses of LINE-1 in the Dentate Gyrus, Striatum and Prefrontal Cortex to Chronic Neurotoxic Methamphetamine: A Study in Rat Brain. Genes. 11. PMID 32231019 DOI: 10.3390/Genes11040364  0.383
2018 Tong J, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, Mizrahi R, Boileau I, Furukawa Y, McCluskey T, Sailasuta N, Kish SJ. Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. Drug and Alcohol Dependence. 190: 20-28. PMID 29960919 DOI: 10.1016/J.Drugalcdep.2018.05.021  0.56
2018 Gemechu JM, Sharma A, Yu D, Xie Y, Merkel OM, Moszczynska A. Characterization of Dopaminergic System in the Striatum of Young Adult Park2-/- Knockout Rats. Scientific Reports. 8: 1517. PMID 29367643 DOI: 10.1038/S41598-017-18526-0  0.358
2017 Flack A, Persons AL, Kousik SM, Napier TC, Moszczynska A. Self-Administration of Methamphetamine Alters Gut Biomarkers of Toxicity. The European Journal of Neuroscience. PMID 28661099 DOI: 10.1111/Ejn.13630  0.321
2016 Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ. Do glutathione levels decline in aging human brain? Free Radical Biology & Medicine. PMID 26845616 DOI: 10.1016/J.Freeradbiomed.2016.01.029  0.548
2016 Killinger BA, Moszczynska A. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. Journal of Neurochemistry. 136: 510-25. PMID 26465779 DOI: 10.1111/Jnc.13391  0.363
2015 Moszczynska A, Flack A, Qiu P, Muotri AR, Killinger BA. Neurotoxic Methamphetamine Doses Increase LINE-1 Expression in the Neurogenic Zones of the Adult Rat Brain. Scientific Reports. 5: 14356. PMID 26463126 DOI: 10.1038/Srep14356  0.37
2014 Chauhan H, Killinger BA, Miller CV, Moszczynska A. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum. International Journal of Molecular Sciences. 15: 5884-906. PMID 24717411 DOI: 10.3390/Ijms15045884  0.377
2014 Killinger B, Shah M, Moszczynska A. Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats. Journal of Neurochemistry. 128: 764-75. PMID 24151877 DOI: 10.1111/Jnc.12496  0.376
2013 Liu B, Traini R, Killinger B, Schneider B, Moszczynska A. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity. Experimental Neurology. 247: 359-72. PMID 23313192 DOI: 10.1016/J.Expneurol.2013.01.001  0.401
2011 Moszczynska A, Yamamoto BK. Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo. Journal of Neurochemistry. 116: 1005-17. PMID 21166679 DOI: 10.1111/J.1471-4159.2010.07147.X  0.382
2010 Yamamoto BK, Moszczynska A, Gudelsky GA. Amphetamine toxicities: classical and emerging mechanisms. Annals of the New York Academy of Sciences. 1187: 101-21. PMID 20201848 DOI: 10.1111/J.1749-6632.2009.05141.X  0.381
2007 Moszczynska A, Saleh J, Zhang H, Vukusic B, Lee FJ, Liu F. Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity. Journal of Molecular Neuroscience : Mn. 32: 217-27. PMID 17873367 DOI: 10.1007/S12031-007-0037-0  0.338
2007 Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. The Embo Journal. 26: 2127-36. PMID 17380124 DOI: 10.1038/Sj.Emboj.7601656  0.393
2004 Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Why is parkinsonism not a feature of human methamphetamine users? Brain : a Journal of Neurology. 127: 363-70. PMID 14645148 DOI: 10.1093/Brain/Awh046  0.58
2002 Ross BM, Moszczynska A, Peretti FJ, Adams V, Schmunk GA, Kalasinsky KS, Ang L, Mamalias N, Turenne SD, Kish SJ. Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug and Alcohol Dependence. 67: 73-9. PMID 12062780 DOI: 10.1016/S0376-8716(02)00022-4  0.598
2001 Ross BM, Mamalias N, Moszczynska A, Rajput AH, Kish SJ. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. Neuroscience. 102: 899-904. PMID 11182251 DOI: 10.1016/S0306-4522(00)00501-7  0.588
2000 Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Anthony RA, Wickham D, Kish SJ. Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Molecular Psychiatry. 5: 664-72. PMID 11126397 DOI: 10.1038/Sj.Mp.4000760  0.576
2000 Ross BM, Eder K, Moszczynska A, Mamalias N, Lamarche J, Ang L, Pandolfo M, Rouleau G, Kirchgessner M, Kish SJ. Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 294-300. PMID 10752579 DOI: 10.1002/1531-8257(200003)15:2<294::Aid-Mds1013>3.0.Co;2-D  0.583
1999 Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Research. 821: 407-13. PMID 10064828 DOI: 10.1016/S0006-8993(99)01123-3  0.548
1998 Moszczynska A, Turenne S, Kish SJ. Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neuroscience Letters. 255: 49-52. PMID 9839724 DOI: 10.1016/S0304-3940(98)00711-3  0.563
1998 Ross BM, Moszczynska A, Erlich J, Kish SJ. Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease. Neuroscience. 83: 791-8. PMID 9483562 DOI: 10.1016/S0306-4522(97)00454-5  0.597
1998 Ross BM, Moszczynska A, Erlich J, Kish SJ. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. Journal of Neurochemistry. 70: 786-93. PMID 9453575 DOI: 10.1046/J.1471-4159.1998.70020786.X  0.573
1997 Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ. Phospholipid biosynthetic enzymes in human brain. Lipids. 32: 351-8. PMID 9113621 DOI: 10.1007/S11745-997-0044-X  0.558
1996 Ross BM, Moszczynska A, Kalasinsky K, Kish SJ. Phospholipase A2 activity is selectively decreased in the striatum of chronic cocaine users. Journal of Neurochemistry. 67: 2620-3. PMID 8931499 DOI: 10.1046/J.1471-4159.1996.67062620.X  0.604
Show low-probability matches.